Summit Global Investments Harmony Biosciences Holdings, Inc. Transaction History
Summit Global Investments
- $1.34 Billion
- Q1 2024
A detailed history of Summit Global Investments transactions in Harmony Biosciences Holdings, Inc. stock. As of the latest transaction made, Summit Global Investments holds 19,357 shares of HRMY stock, worth $584,000. This represents 0.05% of its overall portfolio holdings.
Number of Shares
19,357
Previous 16,173
19.69%
Holding current value
$584,000
Previous $522,000
24.52%
% of portfolio
0.05%
Previous 0.03%
Shares
3 transactions
Others Institutions Holding HRMY
# of Institutions
213Shares Held
44MCall Options Held
68.4KPut Options Held
52.1K-
Valor Management LLC Chicago, IL11.2MShares$338 Million100.0% of portfolio
-
Black Rock Inc. New York, NY5.92MShares$179 Million0.0% of portfolio
-
Vanguard Group Inc Valley Forge, PA3.63MShares$109 Million0.0% of portfolio
-
Vivo Capital, LLC Palo Alto, CA2.61MShares$78.6 Million11.71% of portfolio
-
Pacer Advisors, Inc. Malvern, PA2.49MShares$75.3 Million0.22% of portfolio
About Harmony Biosciences Holdings, Inc.
- Ticker HRMY
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 59,161,400
- Market Cap $1.78B
- Description
- Harmony Biosciences Holdings, Inc., a commercial-stage pharmaceutical company, develops and commercializes therapies for patients with rare neurological disorders in the United States. Its product, WAKIX is a medication for the treatment of excessive daytime sleepiness in adult patients with narcolepsy. The company was formerly known as Harmony ...